Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer

Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer

The results of a preplanned cardiac safety analysis of global longitudinal strain (GLS), and troponin-I (TnI) and brain natriuretic peptide (BNP) levels in the phase II study of paclitaxel, trastuzumab, and pertuzumab (THP) for metastatic HER2-positive breast cancer are reported. There were no stati...

Full description

Bibliographic Details
Main Authors: Yu, Anthony F., Manrique, Carlos, Pun, Shawn, Liu, Jennifer E., Mara, Elton, Fleisher, Martin, Patil, Sujata, Jones, Lee W., Steingart, Richard M., Hudis, Clifford A., Dang, Chau T.
Format: Online
Language:English
Published: AlphaMed Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828117/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828117/

Similar Items